Primary Cells Market

Primary Cells Market by Type (Human Primary Cells, Animal Primary Cells), Origin (Hematopoietic, Blood, Skin, Gastrointestinal, Hepatocytes, Renal, Skeleton & Muscles), End User (Life Science Research & Research Institutes) - Global Forecast to 2023

Report Code: BT 6489 Jul, 2018, by marketsandmarkets.com

[114 Pages Report] The primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 666.0 million in 2017 at a CAGR of 8.5% from 2018–2023. The base year for this study is 2017 and the forecast period is 2018–2023.

The objectives of this study are as follows:

  • To define, describe, and forecast the primary cells market by origin, type, end user and region
  • To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To identify micromarkets and the drivers, opportunities, and trends affecting the growth of the market
  • To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
  • To track and analyze competitive developments such as acquisitions; product launches, expansions; and R&D activities in the primary cells market

Drivers

Increasing cancer research

Primary cells are cells isolated from human or animal tissues. These cells are ideal models for cancer biomarker discovery and drug screening. They are also used to understand the biochemical pathways of cellular interactions.

In cancer research, primary cells are often exposed to heavy radiation doses, chemicals, and viruses, which transforms these cells into cancer cells through genetic mutations and the introduction of oncogenes. In this way, the molecular-level mechanism and cause of cancer, as well as the altered signaling pathways of cancerous cells, can be studied.

Advantages of primary human cells over cell lines

Primary human cells have a wide range of advantages over in vitro cell lines; they provide reliable tissue-specific responses in a biologically relevant microenvironment. Drug responses in cell lines may not provide false responses in a cellular context. Moreover, primary human cells are cost-effective and help in reducing expenditure on animal models required for in vivo studies. Pre-screened primary cells help in representing signaling in vivo very closely. Owing to this, pharmaceutical and biotechnology companies as well as CROs are increasingly shifting to primary human cells for their lead identification and optimization processes in drug discovery.

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by type and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.

Various secondary sources such as the International Diabetes Federation (IDF), National Institutes of Health (NIH), Department of Health and Social Care (DHSC), International Cell Line Authentication Committee (ICLAC), National Cancer Institute (NCI), Cancer Research UK, Israel Cancer Research Fund (ICRF), Breast Cancer Research Foundation (BCRF), Centre for Cellular & Molecular Biology (CCMB), Centers for Disease Control and Prevention (CDC), and PubMed have been used to identify and collect information useful for this extensive commercial study of the primary cells market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess the prospects of the primary cells market. The breakdown of profiles of primaries is shown in the figure below:

Primary Cells Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in this market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (Canada), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK).

Target Audience for this Report:

  • Manufacturers and vendors of biologics
  • Distributors of human and animal primary cells
  • Venture capitalists
  • Various research and consulting firms
  • Research laboratories
  • Cancer Research Institutes
  • Biopharmaceutical companies
  • Government associations dedicated to primary cells research

Product Launches


Month & Year

Company Name

Segment

 Product

May 2018

Lonza (Switzerland)

Human Primary Cells

Lonza expanded its primary cells portfolio and added hepatic stellate cells, Kupffer cells, and liver-derived endothelial cells to its hepatocytes portfolio

February 2017

Lonza (Switzerland)

Human Primary Cells

IPF Airway Cells


Expansions


Month & Year

Company Name

Region

Description

April 2018

STEMCELL Technologies (Canada)

Canada

Received USD 45 million from the Governments of Canada and British Columbia to help the company build an advanced manufacturing facility

January 2017

STEMCELL Technologies (Canada)

UK

Opened its New Office and Laboratories in Cambridge, UK, in order to increase its presence in the European primary cells market


Acquisitions


Month & Year

Company 1

Company 2

Description

November 2016

Thermo Fisher Scientific (US)

MTI-Global Stem (US)

To increase and expand its primary and stem cell portfolio

November 2015

Merck KGaA (Germany)

Sigma-Aldrich (US)

To increase and expand its primary cells portfolio


Scope of the Report:

This report categorizes the primary cells market into the following segments:

Primary Cells Market, By Origin

  • Hematopoietic Cells
  • Skin Cells
  • Gastrointestinal Cells
  • Liver Cells
  • Lung Cells
  • Renal Cells
  • Heart Cells
  • Skeletal & Muscle Cells
  • Other Primary Cells

Primary Cells Market, By Type

  • Human Primary Cells
  • Animal Primary Cells

Primary Cells Market, By End User

  • Life Science Research Companies
  • Research Institutes

Primary Cells Market, By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • Italy
    • France
    • UK
    • RoE
  • Asia
    • China
    • Japan
    • Rest of Asia
  • Rest of the World

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunity Assessment: A detailed report underlining the various growth opportunities presented in the market

The global primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%. Growth in the primary cells market is mainly driven by factors such as increasing cancer research; the advantages of primary human cells over cell lines; the increasing demand for monoclonal antibodies; rapid growth in the biotechnology and biopharmaceutical industries, partnerships, collaborations, and acquisitions; and increasing pharmaceutical outsourcing.

The global primary cells market is segmented by origin, type, end user, and region. By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung, renal, heart, skeletal & muscle, and other primary cells. The liver cells segment is expected to register the highest CAGR during the forecast period due to their increasing demand in toxicological and pharmacological studies.

Based on type, the market is segmented into human and animal primary cells. The human primary cells segment is expected to register the highest CAGR during the forecast period owing to the high adoption of human primary cells in the development of novel cancer therapies. Human primary cells are also extensively used for studying human cancerous cell models, in toxicology studies, and in the cosmetic industry.

On the basis of end user, the market is segmented into life science research companies and research institutes. The life science research companies segment is expected to grow at the highest CAGR during the forecast period. The high growth rate can be attributed to the high adoption of primary cells in cell-based experiments and cancer research in life science research companies as well as the increasing number of R&D facilities globally.

Primary Cells Market

The global primary cells market is dominated by North America, followed by Europe. North America will continue to dominate the global primary cells market during the forecast period, however, Asia is expected to witness the highest CAGR, with the growth in this market centered on China and Japan. Increasing number of players launching new human primary cells for research, expansion of pharmaceutical and biotechnology industries, and increasing prevalence of cancer in the region are the major factors driving the growth of the North American market. However, regulatory concerns regarding primary cell culture contamination will restrain the growth of this market. Some of the major players in the primary cells market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (Canada), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK). These companies have a broad product portfolio with comprehensive features. Key industry players focus on acquisitions to maintain and enhance their position in the primary cells market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 12)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 15)

    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 22)

4 Premium Insights (Page No. - 25)
    4.1 Primary Cells: Market Overview
    4.2 Primary Cells Market Share, By Region & Origin, 2018
    4.3 Primary Cells Market, By Type, 2018–2023 (USD Million)
    4.4 Geographical Snapshot of the Primary Cells Market

5 Market Overview (Page No. - 28)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Cancer Research
                    5.2.1.2 Advantages of Primary Human Cells Over Cell Lines
                    5.2.1.3 Increasing Demand for Monoclonal Antibodies
                    5.2.1.4 Rapid Growth in the Biotechnology and Biopharmaceutical Industries
                    5.2.1.5 Partnerships, Collaborations, and Acquisitions Strengthening Market Growth
                    5.2.1.6 Increasing Pharmaceutical Outsourcing
           5.2.2 Restraints
                    5.2.2.1 Concerns Regarding Primary Cell Culture Contamination
           5.2.3 Opportunities
                    5.2.3.1 Advancing Biomedical Research Using Primary Cells in 3D Culture

6 Primary Cells Market, By Origin (Page No. - 34)
    6.1 Introduction
    6.2 Hematopoietic Cells
    6.3 Skin Cells
    6.4 Gastrointestinal Cells
    6.5 Liver Cells
    6.6 Lung Cells
    6.7 Renal Cells
    6.8 Heart
    6.9 Skeletal and Muscle Cells
    6.10 Other Primary Cells

7 Primary Cells Market, By Type (Page No. - 45)
    7.1 Introduction
    7.2 Human Primary Cells
    7.3 Animal Primary Cells

8 Primary Cells Market, By End User (Page No. - 49)
    8.1 Introduction
    8.2 Life Science Research Companies
    8.3 Research Institutes

9 Primary Cells Market, By Region (Page No. - 53)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 UK
           9.3.2 Italy
           9.3.3 Germany
           9.3.4 France
           9.3.5 RoE
    9.4 Asia
           9.4.1 China
           9.4.2 Japan
           9.4.3 Rest of Asia
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 88)
     10.1 Overview
     10.2 Market Share Ranking, 2017
     10.3 Top Ranking Companies in the Primary Cells Market
     10.4 Competitive Scenario
             10.4.1 Product Launches
             10.4.2 Expansions
             10.4.3 Acquisitions

11 Company Profiles (Page No. - 91)
     11.1 Thermo Fisher Scientific
             11.1.1 Business Overview
             11.1.2 Products Offered
             11.1.3 Recent Developments
             11.1.4 MnM View
     11.2 Merck KGaA
             11.2.1 Business Overview
             11.2.2 Products Offered
             11.2.3 Recent Developments
             11.2.4 MnM View
     11.3 Lonza
             11.3.1 Business Overview
             11.3.2 Products Offered
             11.3.3 Recent Developments
             11.3.4 MnM View
     11.4 Cell Biologics
             11.4.1 Business Overview
             11.4.2 Products Offered
             11.4.3 Recent Developments
     11.5 Promocell
             11.5.1 Business Overview
             11.5.2 Products Offered
             11.5.3 Recent Developments
     11.6 Zenbio
             11.6.1 Business Overview
             11.6.2 Products Offered
             11.6.3 Recent Developments
     11.7 Stem Cell Technologies
             11.7.1 Business Overview
             11.7.2 Products Offered
             11.7.3 Recent Developments
     11.8 ALLCells
             11.8.1 Business Overview
             11.8.2 Products Offered
             11.8.3 Recent Developments
     11.9 American Type Culture Collection (ATCC)
             11.9.1 Business Overview
             11.9.2 Products Offered
             11.9.3 Recent Developments
     11.10 Axol Biosciences
             11.10.1 Business Overview
             11.10.2 Products Offered
             11.10.3 Recent Developments

12 Appendix (Page No. - 108)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (71 Tables)

Table 1 Increasing Funding in National Cancer Institute Research, Us
Table 2 Cancer Research Output and Growth (2010–2014)
Table 3 List of Recent Significant Acquisitions
Table 4 Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 5 Hematopoietic Cells, By Type
Table 6 Cancer Research Output, Growth, and Impact, 2010–2014
Table 7 Primary Hematopoietic Cells Market, By Region, 2016–2023 (USD Million)
Table 8 Primary Skin Cells Market, By Region, 2016–2023 (USD Million)
Table 9 Primary Gastrointestinal Cells Market, By Region, 2016–2023 (USD Million)
Table 10 Primary Liver Cells Market, By Region, 2016–2023 (USD Million)
Table 11 Primary Lung Cells in the Market
Table 12 Primary Lung Cells Market, By Region, 2016–2023 (USD Million)
Table 13 Primary Renal Cells in the Market
Table 14 Primary Renal Cells Market, By Region, 2016–2023 (USD Million)
Table 15 Primary Heart Cells Market, By Region, 2016–2023 (USD Million)
Table 16 Primary Skeletal and Muscle Cells Market, By Region, 2016–2023 (USD Million)
Table 17 Other Primary Cells Market, By Region, 2016–2023 (USD Million)
Table 18 Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 19 Human Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 20 Animal Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 21 Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 22 Primary Cells Market for Life Science Research Companies, By Region, 2016–2023 (USD Million)
Table 23 Primary Cells Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 24 Primary Cells Market, By Region, 2016–2023 (USD Million)
Table 25 North America: Primary Cells Market, By Country, 2016–2023 (USD Million)
Table 26 North America: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 27 North America: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 28 North America: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 29 US: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 30 US: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 31 US: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 32 Canada: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 33 Canada: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 34 Canada: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 35 R&D Expenditure for Science and Technology in Europe, 2005 vs 2015 (USD Million)
Table 36 Europe: Primary Cells Market, By Country, 2016–2023 (USD Million)
Table 37 Europe: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 38 Europe: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 39 Europe: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 40 UK: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 41 UK: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 42 UK: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 43 Italy: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 44 Italy: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 45 Italy: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 46 Germany: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 47 Germany: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 48 Germany: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 49 France: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 50 France: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 51 France: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 52 RoE: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 53 RoE: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 54 RoE: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 55 Growth in the Number of Publications in China and Japan, 2010–2014
Table 56 Asia : Primary Cells Market, By Country, 2016–2023 (USD Million)
Table 57 Asia: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 58 Asia: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 59 Asia: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 60 China: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 61 China: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 62 China: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 63 Japan: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 64 Japan: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 65 Japan: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 66 RoA: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 67 RoA: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 68 RoA: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 69 RoW: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 70 RoW: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 71 RoW: Primary Cells Market, By End User, 2016–2023 (USD Million)


List of Figures (35 Figures)

Figure 1 Primary Cells Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type and Designation
Figure 4 Primary Cells Market: Bottom-Up Approach
Figure 5 Primary Cells Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Primary Cells Market, By Origin, 2018 vs 2023 (USD Billion)
Figure 8 Primary Cells Market, By Type, 2018 vs 2023 (USD Billion)
Figure 9 Primary Cells Market, By End User, 2018 vs 2023 (USD Billion)
Figure 10 Primary Cell Market, By Region, 2018 vs 2023 (USD Billion)
Figure 11 Increasing Cancer Research is Driving the Growth of the Primary Cells Market
Figure 12 North America is Estimated to Command the Largest Market Share in 2018
Figure 13 Human Primary Cells Segment to Register the Highest CAGR During the Forecast Period
Figure 14 Asia to Register the Highest CAGR During the Forecast Period
Figure 15 Primary Cells Market: Drivers, Restraints, & Opportunities
Figure 16 Liver Cells Segment Witness the Highest Growth During the Forecast Period
Figure 17 Human Primary Cells to Witness the Highest Growth During the Forecast Period
Figure 18 Life Science Research Companies to Witness the Highest Growth in the Primary Cells Market During the Forecast Period
Figure 19 Primary Cells Market: Geographic Analysis
Figure 20 North America: Cancer Incidence & Mortality, 2012–2035
Figure 21 North America: Primary Cells Market Snapshot
Figure 22 US: Cancer Incidence & Mortality, 2012–2035
Figure 23 Canada: Cancer Incidence & Mortality, 2012–2035
Figure 24 Europe: Cancer Incidence & Mortality, 2012–2035
Figure 25 UK: Cancer Incidence & Mortality, 2012–2035
Figure 26 CAGR of Publications in Cancer Research, Medicine, and All Disciplines in the UK (2005–2014)
Figure 27 CAGR of Publications in Cancer Research, Medicine, and All Disciplines in Italy (2005–2014)
Figure 28 Germany: Cancer Incidence & Mortality, 2012–2035
Figure 29 Asia: Cancer Incidence & Mortality, 2012–2035
Figure 30 Asia: Primary Cells Market Snapshot
Figure 31 CAGR of Publications in Cancer Research, Medicine, and All Disciplines in China (2005–2014)
Figure 32 Product Launches & Expansions, the Most Adopted Growth Strategy From 2015 to 2018
Figure 33 Thermo Fisher Scientific: Company Snapshot
Figure 34 Merck KGaA: Company Snapshot
Figure 35 Lonza: Company Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 6489
Published ON
Jul, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Primary Cells Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved